Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abdulrahman M. AlHadi"'
Autor:
Ayed A. Shati, Saleh M. Al-Qahtani, Abdullah A. Alsabaani, Syed E. Mahmood, Youssef A. Alqahtani, Khalid M. AlQahtani, Mohammed S. Aldarami, Fahad D. AlAmri, Abdulrahman Saad Alqahtani, Abdulrahman M. AlHadi, Ausaf Ahmad, Fatima A. Riaz
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1222 (2022)
Vaccines are an important part of the COVID-19 pandemic response plan. This cross-sectional study aims to assess the attitude and perception levels of parents toward COVID-19 vaccines for children aged 0–18 years in the Aseer region of Saudi Arabia
Externí odkaz:
https://doaj.org/article/8bafb1a9583b460b935f1916a46ce555
Autor:
Hassan A. Al-Shamahy, Monya Abdullah Yahya El-Zine, Abdulrahman M Alhadi, Abdulrahman A. IshaK
Publikováno v:
New Medical Innovations and Research. 2:01-05
Introduction: Leukemia is a heterogeneous group of hematological disorders that is made up of several diverse and biologically distinct subgroups. Leukemia is the 11th and10th most common cause of cancer morbidity and mortality worldwide, respectivel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eff5571015ccdf0085fb3ea1eb20c6c0
https://doi.org/10.31579/2767-7370/018
https://doi.org/10.31579/2767-7370/018
Autor:
Abdulrahman A. Ishak, Khaled Abdulkareem A Al-Moyed, Hassan A. Al-Shamahy, Abdulrahman M Alhadi
Publikováno v:
Universal Journal of Pharmaceutical Research.
Background and objective: Urinary tract infections (UTIs) are the neglected infection in children from the side of study its clinical symptoms, causative organisms and their antibiotic sensitivity. This investigation searches for determine clinical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98f9ba08ebbb37cdee22df1e06a85c1e
https://doi.org/10.22270/ujpr.v6i4.643
https://doi.org/10.22270/ujpr.v6i4.643
Publikováno v:
Hemoglobin. 44(2)
The response to hydroxyurea (HU) therapy of 44 Yemeni transfusion-dependent β-thalassemia (β-thal) patients in Sana'a City, Yemen, was assessed. All patients were treated with a dose of 15 mg/kg/day HU for 4-10 months. Thirty-six patients responded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bcb98521708c7c60febf4059a9a521e
https://pubmed.ncbi.nlm.nih.gov/32308066
https://pubmed.ncbi.nlm.nih.gov/32308066
Autor:
Abdulrahman M Alhadi, Hafiz A. Al-Nood
Publikováno v:
Qatar Medical Journal
In Yemen, the prevalence of sickle cell trait and β-thalassemia trait are high. The aim of this premarital program is to identify sickle cell and thalassemia carrier couples in Yemen before completing marriages proposal, in order to prevent affected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c0487180d874be84622d502cd93c2b
http://europepmc.org/articles/PMC4080493
http://europepmc.org/articles/PMC4080493